Drug probe.Drug Probe: Thousand Oaks-based Amgen Inc. said the U.S. International Trade Commission has agreed to investigate efforts by Swiss drug maker Roche Holding AG to import a competing anemia anemia (ənē`mēə), condition in which the concentration of hemoglobin in the circulating blood is below normal. Such a condition is caused by a deficient number of erythrocytes (red blood cells), an abnormally low level of hemoglobin drug, Cera, into the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . Amgen, the world's largest biotechnology company, claims that Roche's drug violates U.S. patents Amgen holds on its anemia drug Epogen. Amgen is asking the ITC ITC (Brit) n abbr (= Independent Television Commission) → Fernseh-Aufsichtsgremium ITC n abbr (BRIT) (= Independent Television Commission) → to issue a permanent exclusion order to prohibit pro·hib·it tr.v. pro·hib·it·ed, pro·hib·it·ing, pro·hib·its 1. To forbid by authority: Smoking is prohibited in most theaters. See Synonyms at forbid. 2. importation of Cera into the United States, In addition to the ITC investigation, Amgen is pursuing a federal lawsuit against Roche that was filed in November 8. |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion